Table 4.

Multiple regressions (outcome measure Aβ PET status (positive versus negative) for models 2, 3, and 4 including odds ratio (OR), 95% confidence interval (95% CI), and p value for all included model variables.

Variable	Model 2			Model 3			Model 4			Model 5
	OR	95% CI	p	OR	95% CI	p	OR	95% CI	p	OR	95% CI	p
Age	1.07	0.99, 1.15	0.08	1.06	0.98, 1.16	0.15	1.05	0.96, 1.15	0.26	1.06	0.94, 1.19	0.36
Education	1.07	0.91, 1.25	0.42	1.05	0.88, 1.25	0.57	1.04	0.88, 1.25	0.63	1.05	0.81, 1.32	0.81
Gender	1.00	0.44, 2.24	>0.99	0.75	0.30, 1.87	0.53	0.77	0.29, 2.03	0.59	1.84	0.49, 6.96	0.36
APOE ɛ4	7.11	2.60, 19.41	<0.001	7.02	2.37, 20.91	<0.001	7.36	2.37, 22.87	<0.001	14.69	2.45, 88.15	0.004
Aβ42/40				0.70	0.41, 1.22	0.21	0.68	0.39, 1.21	0.19	0.48	0.21, 1.09	0.08
ptau-181				2.38	2.38, 3.89	<0.001	2.48	1.49, 4.12	<0.001	3.65	1.83, 7.27	<0.001
CRP							1.00	0.98, 1.02	0.86	1.01	0.97, 1.05	0.78
SAA							1.00	1.00, 1.00	0.73	1.00	0.99, 1.01	0.83
sVCAM1							1.08	0.72, 1.61	0.72	1.34	0.57, 3.11	0.50
TNF α							1.15	0.72, 1.82	0.56	1.41	0.71, 2.80	0.32
TARC							1.00	1.00, 1.00	0.83	1.00	1.00, 1.00	0.31
A2M										1.00	1.00, 1.00	0.54
B2M										1.00	0.99, 1.01	0.77
FVII										1.00	1.00, 1.00	0.03
sICAM1										1.00	1.00, 1.00	0.29
TNC										1.00	1.00, 1.00	0.048
FABP3										1.00	1.00, 1.00	0.042
TPO										1.00	1.00, 1.01	0.15
IL18										1.00	1.00, 1.00	0.57
PPY										1.00	1.00, 1.01	0.03
IL7										1.00	0.93, 1.07	>0.99
I309										0.99	0.95, 1.03	0.50
Eotaxin3										1.00	0.97, 1.03	0.77
IL6										1.40	0.52, 3.82	0.50
IL5										2.80	0.83, 9.50	0.10
IL10										1.41	0.26, 7.76	0.69

FABP3, fatty acid binding protein-3; PPY, pancreatic polypeptide; TARC, thymus and activation related chemokine; TNF, tumor necrosis factor.